Georgia State University researchers have created a novel nanoparticle vaccine.
- A nanoparticle influenza vaccine developed at Georgia State University proved effective in mice.
- The researchers combined a pair of influenza proteins in a novel approach to vaccination.
- They plan on loading it onto microneedle patches for skin vaccinations in the next phase of testing.
The possibility of an easy, non-invasive detection method arises.
- A blood test that spots breast cancer five years ahead of clinical signs could give new meaning to "early detection."
- Auto-antibodies for tumor antigens predict the presence of the disease.
- Researchers say the blood test could be clinic-ready in 4-5 years.
Researchers recently discovered an antibody that totally disrupts the influenza virus's ability to replicate; it could be used to design a universal flu vaccine.
- Because the flu mutates so frequently, we have to get a new flu shot every year that's designed for that year's strain of flu.
- But researchers recently discovered an antibody found in an infected patient's blood that prevents the virus from replicating, even across multiple strains. According to researchers, this effect "is just mind-boggling."
- The antibody works by targeting a very specific part of a very specific protein on all flu virions; this piece can't change too much from strain to strain because it is fundamental to the flu's ability to replicate.
Ferrets are not humans, but this new drug is showing promise.
- Researchers at Georgia State University and Emory University tweaked an old drug and found great results.
- None of the ferrets given EIDD-2801 twelve hours after infection developed the flu.
- Those given the drug a day later developed less severe symptoms than the control group or those receiving Tamiflu.
A new immunotherapy treatment is showing positive signs in early-stage clinical trials.
- Clinical trials of an immunotherapy treatment for breast cancer showed positive signs, and the researchers hope to move to larger trials in coming years.
- Immunotherapies train the body's immune system to find and kill cancer cells without harming healthy cells.
- Recent trials of immunotherapies for other cancers have also showed positive signs.